Marie-Ève Ferland

Marie-Ève is a trusted advisor focusing her practice in business law, and more specifically in private mergers and acquisition and corporate finance. With over 15 years’ experience, she’s developed sharp business negotiation skills through her involvement in major transactions within various industries, including in the fields of technologies, medical technologies, entertainment, retail and venture capital. She assists business owners, financial institutions and investors on a daily basis with the planning and roll-out of strategic operations and provides them guidance on maximizing the protection of their rights and investments. She also assists her clients in the negotiation, drafting and execution of various agreements.

Marie-Ève stands out due to her acute business sense, broad experience in strategic transactions, her impeccable work ethic and her numerous professional involvements. She puts her cutting edge expertise to the benefit of her clients and helps them develop tangible solutions rooted in their reality, with an accessible and fundamentally human approach.

Areas of practice

• Public and private mergers and acquisitions
• Corporate financing
• Corporate governance
• Corporate law

Representative work

• Supporting MEDFAR Clinical Solutions, Quebec's leading provider of electronic medical records, in several acquisitions and equity and debt financing rounds.
• Acting for a Quebec-based consolidator in the optical industry in the purchase of multiple clinics across Quebec.
• Advising Desjardins Holding Financier on investments in financial technology, healthcare and real estate companies.
• Supporting a Québec-based technology consulting group of founders in the sale of their business to a US company.
• Representing an architecture and urban planning firm in several acquisitions or divestitures.
• Representing a manufacturer in the orthopedic industry in its acquisition of a competitor.
• Supporting several Quebec companies in the negotiation of equity and debt financing with investment funds and institutional investors.